AB44328
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
10g | 98% | in stock | $6.00 | $4.00 | - + | |
25g | 98% | in stock | $12.00 | $9.00 | - + | |
100g | 98% | in stock | $40.00 | $28.00 | - + | |
500g | 98% | in stock | $48.00 | $34.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AB44328 |
Chemical Name: | 3,4-Dimethoxyaniline |
CAS Number: | 6315-89-5 |
Molecular Formula: | C8H11NO2 |
Molecular Weight: | 153.1784 |
MDL Number: | MFCD00008394 |
SMILES: | COc1cc(N)ccc1OC |
NSC Number: | 21033 |
Complexity: | 119 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Rotatable Bond Count: | 2 |
XLogP3: | 1.4 |
3,4-Dimethoxyaniline finds wide application in chemical synthesis as a versatile building block due to its unique properties. Primarily, it is utilized in the production of various pharmaceutical compounds, agrochemicals, and dyes. In organic synthesis, it serves as a crucial intermediate for the synthesis of diverse heterocyclic compounds, such as benzimidazoles and benzothiazoles.Furthermore, 3,4-Dimethoxyaniline is frequently employed as a reagent in the preparation of novel materials and polymers with tailored properties. Its presence in the chemical industry is instrumental in the development of specialized products with enhanced functionalities. Additionally, it is a valuable compound in the field of medicinal chemistry, serving as a key component in the creation of potential drug candidates with promising biological activities.Overall, the significance of 3,4-Dimethoxyaniline in chemical synthesis lies in its valuable role as a versatile building block for the creation of diverse compounds with applications across various sectors.
Acta crystallographica. Section E, Structure reports online 20081101
Acta crystallographica. Section E, Structure reports online 20081101
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080601
Biochemical pharmacology 20080401
Molecular cancer therapeutics 20040301